On February 20, 2025, XRHealth announced the acquisition of RealizedCare, bolstering its leadership in the digital therapeutics field through AI-driven solutions for chronic pain and mental health.
Strategic Growth Through Acquisitions
XRHealth’s latest acquisition of RealizedCare follows a strategic expansion pattern that began in 2023 with the purchases of NeuroReality and Amelia Virtual Care [1][2]. The Boston-based company has established itself as a frontrunner in therapeutic virtual reality, with its platform currently serving over 2,000 clinicians and facilitating more than 1 million extended reality (XR) therapy sessions worldwide [1]. This consolidation strengthens XRHealth’s position as the largest AI-driven therapeutic XR platform globally [2].
Enhanced Therapeutic Capabilities
The integration of RealizedCare brings significant technological advancement to XRHealth’s platform. The acquired company’s platform, developed in collaboration with prestigious institutions including Oxford University and Massachusetts General Hospital, incorporates evidence-based Cognitive Behavioral Therapy (CBT) protocols [1]. A key feature is RealizedCare’s AI-powered triage tool, which optimizes patient care by assessing individual needs and directing them to appropriate digital interventions [1]. This automated assessment system aligns with XRHealth’s value-based care approach, potentially reducing unnecessary treatments while improving patient outcomes.
Leadership Integration and Future Direction
As part of the acquisition, RealizedCare’s Founder & CEO Aaron Gani has been appointed as General Manager of XRHealth US [1][2]. Gani, who previously served as Chief Technology Officer at Humana and currently chairs the Digital Therapeutics Alliance board, brings valuable healthcare technology expertise to the role [1]. The strategic integration aims to expand access to evidence-based care solutions, particularly focusing on chronic pain management and mental health conditions [1].
Industry Impact and Future Prospects
XRHealth’s CEO Eran Orr emphasizes that this acquisition represents more than just business expansion - it’s about reshaping healthcare delivery through the convergence of mixed reality, extended reality, and AI-driven insights [1][2]. The company is demonstrating its latest solutions at the ViVE conference in Nashville from February 16-19, 2025 [2], showcasing how the enhanced platform will contribute to the evolution of immersive, value-based care in the digital therapeutics landscape.